Linked Life Data

20087165

Source:http://linkedlifedata.com/resource/pubmed/id/20087165

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-2-11
pubmed:abstractText
To maximize the palliative benefits of capecitabine and oxaliplatin for patients with refractory squamous cell carcinoma of the head and neck (SCCHN).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1538-2990
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
339
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
148-51
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.
pubmed:affiliation
Department of Medicine, J.G. Brown Cancer Center, University of Louisville, Kentucky 40202, USA. g0rabi01@louisville.edu
pubmed:publicationType
Journal Article, Clinical Trial